이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced Paresis (VAST-LDH)

2026년 8월 12일 업데이트: Teppo Jarvinen, Helsinki University Central Hospital

Validation of a Methodology Using Isometric Dynamometer for Ankle Strength Assessment to Quantify LDH-induced Paresis

Lumbar disc herniation (LDH) is a common condition that may cause lower limb motor weakness (paresis), particularly affecting ankle dorsiflexion and plantarflexion. Although motor deficits are clinically important and may influence treatment decisions, objective and standardized methods for quantifying the severity of paresis are lacking. Current clinical assessment mainly relies on manual muscle testing, which is subjective and has limited sensitivity, while isokinetic dynamometry, the reference standard for muscle strength assessment, is expensive and impractical for routine clinical use.

This prospective validation study aims to evaluate a clinically feasible isometric ankle strength measurement method based on a handheld dynamometer fixed with an external strap to eliminate examiner-dependent resistance. The study will be conducted in two sequential phases. First, validity and reliability of the method will be established in healthy adult volunteers by comparing measurements with those obtained using an isokinetic dynamometer. Second, the method will be applied in patients with LDH-induced lower limb paresis to determine its performance across a broader range of muscle strength values and its clinical applicability.

Outcome measures include maximal isometric ankle dorsiflexion and plantarflexion force, time to peak force, manual muscle testing (Medical Research Council scale), patient-reported weakness using a Numeric Rating Scale, Lower Extremity Functional Scale (LEFS) scores, and functional ankle strength tests. Validity will be assessed using correlation analyses and Bland-Altman agreement analysis, while intra- and inter-rater reliability will be evaluated using intraclass correlation coefficients, coefficient of variation, standard error of measurement, and minimum detectable change.

The study seeks to establish a reliable, valid, and clinically practical method for objective assessment of ankle muscle strength in patients with LDH-induced paresis. Such a method could improve clinical evaluation, enable objective monitoring of recovery, facilitate future clinical research, and support treatment decision-making.

연구 개요

상세 설명

Lumbar disc herniation (LDH) is one of the most common causes of lumbar radiculopathy and may result in lower limb motor weakness due to nerve root compression. While radicular pain often improves with conservative treatment, motor deficits may persist, recover slowly, or require surgical intervention. Despite the clinical importance of paresis, objective quantification of muscle weakness remains challenging because no standardized, practical, and validated measurement method is routinely available for clinical use.

Current clinical assessment primarily relies on manual muscle testing (MMT), which uses an ordinal grading system and is inherently subjective. MMT is limited by examiner experience, strength, and the inability to detect small but clinically meaningful changes in muscle function. Isokinetic dynamometry is widely regarded as the reference standard for objective muscle strength assessment because of its high accuracy and reproducibility. However, the equipment is expensive, non-portable, requires specialized training, and is therefore unsuitable for routine outpatient assessment or repeated follow-up measurements.

This study aims to validate a portable isometric ankle strength measurement method using a handheld dynamometer secured with an external fixation strap, minimizing examiner-related variability. The ultimate goal is to develop a clinically feasible method capable of objectively quantifying ankle dorsiflexion and plantarflexion strength in patients with LDH-induced paresis.

The study is designed as a prospective observational validation study conducted at Helsinki University Hospital. It consists of two consecutive phases.

During the first phase, healthy adult volunteers will undergo repeated ankle strength measurements using both the investigational handheld dynamometer method and an isokinetic dynamometer. This phase will establish criterion validity by comparing the handheld measurements with the reference standard. In addition, intra-rater and inter-rater reliability of the handheld method will be assessed through repeated measurements performed by different examiners.

If adequate validity and reliability are demonstrated, the second phase will recruit patients diagnosed with lumbar disc herniation presenting with clinically verified lower limb paresis. The objective of this phase is to evaluate whether the measurement method performs across the full spectrum of muscle weakness encountered in clinical practice and to determine its clinical relevance.

Primary measurements include maximal isometric ankle dorsiflexion and plantarflexion force and time to peak force. Secondary assessments include manual muscle testing according to the Medical Research Council grading system, patient-reported weakness using an 11-point Numeric Rating Scale, Lower Extremity Functional Scale (LEFS), and functional performance tests consisting of repeated toe raises and heel raises.

Criterion validity will be evaluated by comparing handheld dynamometer measurements with isokinetic dynamometer measurements using Pearson or Spearman correlation coefficients, linear regression analyses, and Bland-Altman plots to assess agreement and systematic bias. Construct validity will be examined by correlating objective strength measurements with patient-reported weakness, LEFS scores, and functional performance tests. Reliability will be assessed using intraclass correlation coefficients for both intra-rater and inter-rater agreement, together with coefficient of variation, standard error of measurement, and minimum detectable change.

Approximately 35 healthy volunteers and 35 patients with LDH-induced paresis will be recruited to allow for participant dropout while maintaining adequate statistical power based on previous validation studies.

The study involves no therapeutic intervention and poses minimal risk. Participants will undergo standardized muscle strength testing and complete patient-reported outcome measures. Any discomfort, such as muscle cramps or transient fatigue during testing, will be documented. Participants demonstrating clinically significant deterioration in muscle strength during the study will be referred for further clinical evaluation according to standard practice.

By establishing a valid, reliable, and practical method for objective ankle strength assessment, this study aims to improve the evaluation and longitudinal monitoring of patients with LDH-induced paresis. The validated methodology may facilitate future clinical trials, improve outcome assessment, enable earlier recognition of neurological recovery or deterioration, and support evidence-based treatment decisions in patients with lumbar disc herniation.

연구 유형

중재적

등록 (추정된)

70

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Uusimaa
      • Helsinki, Uusimaa, 핀란드, 00290
        • Helsinki University Central Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

예

설명

First phase

Inclusion Criteria:

  • Aged 18-65 years old
  • No pathology affecting ankle dorsiflexion or plantarflexion strength

Exclusion Criteria:

- Pathology affecting ankle dorsiflexion or plantarflexion strength

Second phase

Inclusion Criteria:

  • Aged 18-65 years old
  • LDH-induced muscle weakness of ankle dorsiflexion or plantarflexion

Exclusion Criteria:

- No muscle weakness induced by herniated lumbar disc

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
다른: Study participant
Person participating in validity and reliability assessment
Ankle dorsiflexion and plantarflexion isometric maximal voluntary contraction strength test

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Criterion validity of the isometric handheld dynamometer
기간: At baseline (first measurement session; Day 0)
Agreement between the investigational isometric handheld dynamometer (HHD) measurement method and the reference standard isokinetic dynamometer (IKD) for maximal ankle dorsiflexion and plantarflexion strength.
At baseline (first measurement session; Day 0)
Construct validity of the handheld dynamometer
기간: At baseline (first measurement session; Day 0)
Correlation of HHD measurements with patient-reported weakness (Numerical Rating Scale), Lower Extremity Functionality Scale questionnaire, manual muscle testing (Medical Research Council grade) and functional ankle performance tests.
At baseline (first measurement session; Day 0)
Intra-rater reliability of the handheld dynamometer
기간: At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Test-retest reliability of ankle dorsiflexion and plantarflexion strength measurements obtained by the same examiner.
At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Inter-rater reliability of the handheld dynamometer
기간: At the second measurement session, within 7 days after baseline
Agreement between measurements performed by different examiners
At the second measurement session, within 7 days after baseline

기타 결과 측정

결과 측정
측정값 설명
기간
Maximal isometric ankle dorsiflexion strength
기간: At baseline (first measurement session; Day 0)
Maximum voluntary isometric dorsiflexion force measured using the handheld dynamometer
At baseline (first measurement session; Day 0)
Maximal isometric ankle plantarflexion strength
기간: At baseline (first measurement session; Day 0)
Maximum voluntary isometric plantarflexion force measured using the handheld dynamometer.
At baseline (first measurement session; Day 0)
Time to peak force
기간: At baseline (first measurement session; Day 0)
Time required to reach maximal voluntary isometric force during dorsiflexion and plantarflexion.
At baseline (first measurement session; Day 0)
Manual Muscle Testing (Medical Research Council scale)
기간: At baseline (first measurement session; Day 0)
Ankle muscle strength (plantarflexion and dorsiflexion) assessed using the Medical Research Council (MRC) 0-5 manual muscle testing scale (0 = no muscle contraction, 5 = normal strength)
At baseline (first measurement session; Day 0)
Participant-reported lower limb weakness (Numeric Rating Scale)
기간: At baseline (first measurement session; Day 0)
Self-reported severity of lower limb weakness measured using an 11-point Numeric Rating Scale (0 = no weakness, 10 = worst imaginable weakness).
At baseline (first measurement session; Day 0)
Participant reported function (Lower Extremity Functional Scale, LEFS)
기간: At baseline (first measurement session; Day 0)
Lower extremity function assessed using the Lower Extremity Functional Scale (score range 0-80, higher scores indicate better function).
At baseline (first measurement session; Day 0)
Functional ankle performance testing (heel raises, toe raises)
기간: At baseline (first measurement session; Day 0)
Functional ankle performance assessed by the maximum number of heel raises (plantarflexion) and toe raises (dorsiflexion).
At baseline (first measurement session; Day 0)
Participant-reported discomfort during measurements
기간: From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline
Occurrence of adverse symptoms during testing, including but not limited to muscle cramps, discomfort, or pain.
From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 8월 10일

기본 완료 (추정된)

2026년 10월 1일

연구 완료 (추정된)

2026년 12월 1일

연구 등록 날짜

최초 제출

2026년 7월 8일

QC 기준을 충족하는 최초 제출

2026년 8월 12일

처음 게시됨 (실제)

2026년 8월 13일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 8월 13일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 8월 12일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

De-identified individual participant data underlying the results reported in the publication, including ankle strength measurements, functional outcome measures, and participant characteristics.

IPD 공유 기간

10 years after publication

IPD 공유 액세스 기준

Researchers who provide a methodologically sound research proposal.

Data will be available upon reasonable request to the principal investigator, subject to institutional approval, applicable legislation, and a data sharing agreement.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다